Cargando…
Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report
BACKGROUND: Anti-IgLON5 antibody-related encephalopathy is a recently discovered and rare autoimmune disease, and its diagnosis and treatment are more challenging than for other autoimmune encephalopathic diseases. Sleep disorder is the most prominent symptom of the disease. It can also present with...
Autores principales: | Wang, Yuting, Wu, Xiuling, Lu, Baoquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968182/ https://www.ncbi.nlm.nih.gov/pubmed/33731000 http://dx.doi.org/10.1186/s12883-021-02145-4 |
Ejemplares similares
-
Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy
por: Brunetti, Valerio, et al.
Publicado: (2019) -
IgLON5 disease responsive to immunotherapy
por: Bonello, Michael, et al.
Publicado: (2017) -
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)